Therapy News and Research

RSS

New program makes movement-based training more convenient and assessable to adults with cerebral palsy

Forty-one-year-old Laura Gable has lived her entire life with cerebral palsy, a neurological disorder that appears in infancy or early childhood, and permanently affects body movement and posture.

4 Apr 2007

Cost-effectiveness analysis of variceal ligation vs. beta-blockers for primary prevention of variceal bleeding

Endoscopic variceal ligation is cost-effective relative to beta-blockers for the prevention of variceal bleeding in cirrhotic patients if quality of life-years are considered.

4 Apr 2007

Each individual with autism accrues about $3.2 million in costs to society over lifetime

...with lost productivity and adult care being the most expensive components, according to a report in the April issue of Archives of Pediatrics & Adolescent Medicine, a theme issue on autism spectrum disorders.

4 Apr 2007

Intensive therapy helps in battle against bipolar disorder

New results from the largest federally funded bipolar study ever conducted show that patients who receive psychotherapy in addition to medication get better faster from bipolar disorder's debilitating depression and stay better longer, according to a University of Colorado at Boulder researcher involved in the study.

4 Apr 2007

Women who initiate hormone therapy closer to menopause tend to have a reduced risk of coronary heart disease

Studies examining the effects of the use of postmenopausal hormone therapy on coronary heart disease (CHD) have yielded mixed results, depending on the type of study conducted. There may be a number of reasons for the differences, including the timing of initiation of hormone therapy, according to background information in the article.

4 Apr 2007

Surveillance for emergence of neuraminidase inhibitor resistant influenza viruses critically important

Use of certain common antiviral drugs during a recent influenza B epidemic in Japan showed the development of viruses with partial resistance to the drugs, according to a study in the April 4 issue of JAMA.

4 Apr 2007

Targeted therapies improve colon cancer survival rates

People diagnosed with advanced colorectal cancer that has spread to distant organs, such as White House spokesman Tony Snow, are much more likely to survive today than even just a few years ago, due to the recent and continued emergence of improved therapies, say cancer experts.

3 Apr 2007

Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause

Secondary analyses of findings from the Women's Health Initiative (WHI) suggest that women who begin hormone therapy within 10 years of menopause may have less risk of coronary heart disease (CHD) due to hormone therapy than women farther from menopause.

3 Apr 2007

Multimechanism-targeted therapy for migraine more effective than single medications

Combining two different types of treatment for migraine results in better symptom relief than taking either one of the medications, according to a study in the April 4 issue of JAMA.

3 Apr 2007

New computerized system for chemotherapy patients at Beth Israel Deaconess Medical Center

A new computerized system for chemotherapy patients promises to advance Beth Israel Deaconess Medical Center's patient safety effort by establishing automatic standards for all treatment plans.

3 Apr 2007

Millions of children living with HIV/AIDS in developing countries need immediate access to treatment

There is an immediate need for the provision of antiretroviral therapy developed for children, including smaller pills and combination therapies, as well as enhanced medical training to provide care to HIV-positive children in developing countries, according to an American Academy of Pediatrics policy statement published on Monday in the April issue of the journal Pediatrics, the AP/San Francisco Chronicle reports.

3 Apr 2007

Embolic protection and platelet inhibition during renal artery stenting

High blood pressure is the most common chronic medical condition in the United States, and the most common identifiable cause is narrowing of a kidney artery, called renal artery stenosis.

3 Apr 2007

Long-term safety of drug-eluting stents in off-label use

Research presented at the American College of Cardiology's Innovation in Intervention: i2 Summit 2007 in New Orleans, La, paints a picture of the "real world" use of drug-eluting stents and offers new insight into the connection between blood clotting, or thrombosis, in the stent - a dangerous complication - and adherence and responsiveness to anti-clotting medication.

3 Apr 2007

Advances in clinical cardiology

Three studies being presented at the American College of Cardiology's Innovation in Intervention: i2 Summit 2007 in New Orleans, La., highlight the breadth of research propelling advances in clinical cardiology.

3 Apr 2007

Stem cell therapy shows promise for degenerative diseases of the eye

For the millions of Americans whose vision is slowly ebbing due to degenerative diseases of the eye, the lowly neural progenitor cell may be riding to the rescue.

3 Apr 2007

Trial of percutaneous coronary intervention added to optimal medical therapy in patients with stable coronary heart disease

Percutaneous coronary interventions (PCI) involve opening partially blocked arteries to improve blood flow to the heart. These procedures are performed more than 1 million times a year.

3 Apr 2007

New treatment possibilities for Huntington's disease

Howard Florey Institute have opened up new treatment possibilities for Huntington's disease by proving a scientific theory incorrect.

3 Apr 2007

Few surgeons routinely refer breast cancer patients for reconstruction

Forty-four percent of surgeons do not refer the majority of their breast cancer patients to a plastic surgeon prior to the initial surgery when the woman is choosing her treatment course, according to a new study by researchers at the University of Michigan Comprehensive Cancer Center.

2 Apr 2007

Dual renin system blocking drug combo provides additional blood pressure-lowering effects

A combination of two medicines that act against the effects of the enzyme renin are more effective in lowering blood pressure than either of the medicines alone, according to a study presented today at the American College of Cardiology's 56th Annual Scientific Session.

2 Apr 2007

Tilarginine does not reduce risk of death after heart attack

The medication tilarginine, a drug that was believed could be beneficial for patients who develop cardiogenic shock (low blood pressure due to impaired cardiac function) after a heart attack, did not reduce the risk of death up to six months after a heart attack, according to a JAMA study published online March 26.

2 Apr 2007

Therapy News and Research

New program makes movement-based training more convenient and assessable to adults with cerebral palsy

Cost-effectiveness analysis of variceal ligation vs. beta-blockers for primary prevention of variceal bleeding

Each individual with autism accrues about $3.2 million in costs to society over lifetime

Intensive therapy helps in battle against bipolar disorder

Women who initiate hormone therapy closer to menopause tend to have a reduced risk of coronary heart disease

Surveillance for emergence of neuraminidase inhibitor resistant influenza viruses critically important

Targeted therapies improve colon cancer survival rates

Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause

Multimechanism-targeted therapy for migraine more effective than single medications

New computerized system for chemotherapy patients at Beth Israel Deaconess Medical Center

Millions of children living with HIV/AIDS in developing countries need immediate access to treatment

Embolic protection and platelet inhibition during renal artery stenting

Long-term safety of drug-eluting stents in off-label use

Advances in clinical cardiology

Stem cell therapy shows promise for degenerative diseases of the eye

Trial of percutaneous coronary intervention added to optimal medical therapy in patients with stable coronary heart disease

New treatment possibilities for Huntington's disease

Few surgeons routinely refer breast cancer patients for reconstruction

Dual renin system blocking drug combo provides additional blood pressure-lowering effects

Tilarginine does not reduce risk of death after heart attack

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News